Latent tuberculous infection in the United States and Canada: who completes treatment and why?

Abstract

Less than half of treatment initiators completed treatment in our multisite study. Addressing tangible issues such as not having health insurance, toxicity concerns, and clinic accessibility could help to improve treatment completion rates.